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Coronary artery disease accounts for a major cause of left ventricular systolic dys-
function. Left ventricular systolic dysfunction is reversible with revascularization in 
cases of hibernation and stunned myocardium. Revascularization is dependent on not 
only the presence but also the extent of viability, and a viable myocardium is necessary 
for functional recovery. For the detection of viability, non-invasive imaging tech-
niques depend on cell membrane integrity, preserved myocardial metabolism or the 
absence of scar tissue (gadolinium-enhanced magnetic resonance imaging) in areas 
of dysfunctional myocardium. The late enhancement allows for direct visualization of 
necrotic or scarred tissue. By measuring the transmural extent of late enhancement, 
the probability of mechanical improvement can precisely be given. Cardiac MR with 
LGE can predict recovery of left ventricular systolic function after revascularization.
Keywords: viability, myocardial ischemia, cardiac MR, coronary heart disease,  
late gadolinium enhancement
1. Introduction
Coronary heart disease (CHD) is the major cause of heart failure. Among 
patients with ischemic cardiomyopathy, the left ventricular (LV) systolic dysfunc-
tion can result from myocardial necrosis and remodeling, myocardial hibernation, 
or repetitive myocardial stunning. While myocardial necrosis is irreversible, systolic 
dysfunction resulting from hibernation and stunning are potentially reversible 
states of ventricular dysfunction. An estimated 20–40% of patients with chronic 
ischemic LV dysfunction have the potential for significant improvement in LV 
function after revascularization. Revascularization is dependent not only on the 
presence but also the extent of viability, and a critical threshold mass of viable myo-
cardium may be necessary for functional recovery and prognostic benefit to occur 
from revascularization. Assessment of myocardial viability can be done by different 
methods cardiac MRI, PET metabolism and perfusion, Thallium 201/Tc-sestamibi 
SPECT imaging and low dose dobutamine echocardiogram.
Previous studies: Studies in laboratory animals have found that, independent of 
wall motion or infarct age, regions exhibiting gadolinium contrast enhancement at 
least 10 min after the infusion of gadolinium-based contrast agents coincide with 
regions of myocardial necrosis and irreversible myocardial injury; regions that fail 
to enhance are viable [1, 2].
Clinical studies have confirmed that a normal LGE pattern occurs in dysfunc-
tional myocardium that is viable and displays improved contractile function in 
response to low dose (5–10 mcg/kg/min) dobutamine infusion, while central regions 
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with enhancement where the infarct is transmural display no contractile activity in 
response to the dobutamine infusion. Territories that have nontransmural necrosis 
display a diminished contractile response to dobutamine [3]. LGE as a marker of scar 
closely agrees with the finding of matching defects on PET viability scanning [4].
Assessment of myocardial viability can be done by different methods cardiac 
MRI, PET metabolism and perfusion, Thallium 201/Tc-sestamibi SPECT imaging 
and low dose dobutamine echocardiogram. Each imaging modality has its own 
sensitivity and specificity as shown in Table 1.
Further support for these findings comes from a clinical study of 32 patients 
with a proven MI who underwent coronary angiography; LGE, performed 3 or 
14 months after the MI, accurately established the presence, location, and trans-
mural extent of healed Q wave and non-Q wave MI [5]. Large infarcts were pre-
dominantly transmural, while small infarcts were non transmural (Table 2). The 
transmural extent of infarction predicts improvement in left ventricular function. 
In one study of 24 patients, the extent of dysfunctional myocardium that was not 
infarcted or had necrosis comprising <25% of left ventricular wall thickness, as 
established by LGE performed within 1 week of the MI, was the best predictor of 
global improvement in contractility at 3 months [6].
The extent of enhancement with LGE can predict recovery of left ventricular 
systolic function after revascularization [7, 8]. As an example, one study of 50 
patients with coronary artery disease who had left ventricular dysfunction prior 
to surgical or percutaneous revascularization found that 33% of myocardial seg-
ments in 80% of patients had evidence of LGE; 38% of segments had abnormal 
contractility [7]. After revascularization, more dysfunctional segments without 
LGE improved (78 versus 17% with enhancement of more than 75% of the tissue). 
The likelihood of improvement in regional contractility after revascularization 
decreased progressively as the transmural extent of LGE increased. The percent-
age of the left ventricle that was dysfunctional and not enhanced was significantly 
related to the degree of improvement in left ventricular ejection fraction.
Table 1. 
Comparing sensitivity and specificity of various imaging modalities used for assessing myocardial viability.
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Because the size of LGE enhancement may decrease with time, there may be 
predictive value in assessing non enhanced regions of the ventricle. One study 
demonstrated the value of measuring the nonenhancing wall thickness to predict 
improvement in systolic wall thickening [9].
CMR myocardial tagging is another noninvasive method that quantifies local 
myocardial segment shortening throughout the left ventricular myocardium at sites 
across the left ventricular wall thickness [10].
1.1 Cardiomyopathy
The high spatial resolution of CMR enables accurate assessment of ventricular 
volumes, ventricular systolic function (ejection fraction), and myocardial mass and 
wall thickness. Such analysis is useful in the assessment of patients with heart fail-
ure, for the diagnostic evaluation of cardiomyopathy, for prediction of outcomes, 
and may frequently be the preferred diagnostic test.
1.2 Ischemic versus nonischemic cardiomyopathy
High-resolution evaluation of regional ventricular systolic function can help 
differentiate between ischemic and nonischemic cardiomyopathy. LGE, which 
identifies myocardial scar/fibrosis, can also be used to make this distinction.
Table 2. 
Various patterns of cardiac pathology demonstrated on cardiac MRI.
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LGE is present in most patients with ischemic cardiomyopathy (81–100%) 
compared with 12–41% in patients without significant obstructive coronary disease 
[10–12]. Although LGE can be seen in ischemic and nonischemic cardiomyopathies, 
the patterns of LGE tend to be different in the two disorders [11–13]:
Ischemic cardiomyopathy is characterized by subendocardial and/or  
transmural LGE.
In comparison, isolated mid-wall or epicardial enhancement is strongly sugges-
tive of a nonischemic cardiomyopathy. Mid-wall involvement in ischemic cardiomy-
opathy involved segments different from those showing subendocardial LGE [11]. 
Tables 2 and 3 as shown below:
In two studies, LGE similar to that in ischemic cardiomyopathy was seen in 
9–13% of patients with unobstructed coronary arteries [11, 12]. A possible explana-
tion for this finding is recanalization after an MI [12].
LGE also may be seen in hypertrophic cardiomyopathy, myocarditis, sarcoidosis, 
and infiltrative cardiomyopathies such as amyloidosis [13].
Although, several powerful imaging techniques can be used clinically to identify 
viable tissue (and to distinguish it from scar) within dysfunctional LV segments 
Table 3. 
Differentiation of ischemic and nonischemic patterns on cardiac MRI.
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subtended by diseased coronary arteries. CMR has a much higher spatial resolu-
tion in detecting MI than single photon emission computed tomography (SPECT), 
which can miss small or localized sub endocardial infarctions (Figure 1). The 
incidental finding of late gadolinium enhancement (LGE), which reflects an area of 
infarcted myocardium, is independently associated with poor prognosis compared 
with absence of LGE. The ability to better define myocardial infarctions has led to 
studies to evaluate myocardial viability and recovery of wall motion after revascu-
larization (myocardial viability). Wall segments with >50% transmural extent of 
infarction, the likelihood that the segment will regain function after revasculariza-
tion is <8%. Wall segments with <50% transmural extent of infarction, the likeli-
hood of the segment regaining function is much higher.
This information can be used to stratify patients more effectively and to guide 
their subsequent treatment. Although we still lack data from ad hoc randomized 
trials to prove this point unequivocally, a great number of studies in thousands of 
cases have provided compelling evidence that revascularization of dysfunctional 
but viable myocardium may lead to reverse LV remodeling and confer prognostic 
benefits in patients with post ischemic heart failure.
2. Conclusions
The identification of viable myocardium following an MI has important implica-
tions with regard to potential benefits following revascularization. Cardiovascular 
MRI provides a unique tool to assess viability as it offers superior spatial resolution 
and has emerged as the gold standard for the quantification of myocardial scar via 
LGE. The presence of viability was associated with survival benefit from coronary 
artery bypass graft compared with medical therapy alone in patients with severe 
Figure 1. 
Short-axis view of a patient who had an occluded left circumflex artery demonstrating normal appearing 
SPECT, but subendocardial myocardial infarction is easily identified on the CMR image as an area of late 
gadolinium enhancement in the myocardium. CMR = cardiovascular magnetic resonance; SPECT = single-
photon emission computed tomography. Adapted from [14].
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LV dysfunction. In the setting of complex coronary disease and concomitant LV 
dysfunction, a viability assessment via cardiac MRI can provide important diagnos-
tic and prognostic information. Considering the greater spatial resolution compared 
with PET and the wealth of correlative pathological data, DE-MRI represents the 
gold standard in the detection of irreversibly damaged myocardium.
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